| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |